Overview

Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To provide elotuzumab treatment for single-patient use.
Details
Lead Sponsor:
Sundar Jagannath
Collaborator:
Bristol-Myers Squibb
Treatments:
Elotuzumab